Clinical Trial Update: Pathological Basis of MRI Signal Changes in Multiple Sclerosis

View source ↗

Summary

NINDS-sponsored clinical study investigating the pathological basis of MRI signal changes in multiple sclerosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Multiple Sclerosis | Status: RECRUITING